» Articles » PMID: 19780373

Short Half-life Hypnotics Preserve Physical Fitness and Altitude Tolerance During Military Mountainous Training

Overview
Journal Mil Med
Specialty Emergency Medicine
Date 2009 Sep 29
PMID 19780373
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: We study the effect of short half-life hypnotics (zaleplon or zolpidem against placebo) on altitude tolerance in 12 nonacclimated male soldiers (age, 22.1 +/- 0.8 years; height, 177.8 +/- 1.7 cm; weight, 69.8 +/- 1.7 kg).

Methods: Soldiers were trained to practice mountaineering at high altitude (2,533-4,810 meters) during 3 periods (one per medication tested) of 4 days (D1-D4). In each period the nights were spent in a hut (3,613 m). Administration of hypnotics or placebo was then implemented at 9:45 p.m. Nocturnal arterial oxygen saturation (SaO2) and heart rate variability (HRV) were monitored. At 5:00 a.m. and 9:00 p.m. physical fitness was assessed using acute mountain sickness (AMS) score. At 5:00 p.m., a posteffort stand test was carried out to evaluate the orthoparasympathetic imbalance with fatigue.

Results: Nocturnal SaO2 correlated negatively with morning AMS scores (R = -0.820, p < 0.02) and HRV analysis favored the sympathetic modulation. Posteffort stand tests revealed that sympathetic modulation attenuated from D2 to D3 in treated groups.

Conclusion: The present study provides evidence that zolpidem or zaleplon improves sleep and subsequent physical fitness at altitude.

Citing Articles

Using machine learning to determine the correlation between physiological and environmental parameters and the induction of acute mountain sickness.

Wei C, Chen P, Lin S, Huang T, Sun L, Tseng C BMC Bioinformatics. 2022; 22(Suppl 5):628.

PMID: 35641924 PMC: 9153088. DOI: 10.1186/s12859-022-04749-0.


Monitoring stress and allostatic load in first responders and tactical operators using heart rate variability: a systematic review.

Corrigan S, Roberts S, Warmington S, Drain J, Main L BMC Public Health. 2021; 21(1):1701.

PMID: 34537038 PMC: 8449887. DOI: 10.1186/s12889-021-11595-x.


A hypothesis study on a four-period prevention model for high altitude disease.

Liu X, Yang X, Liu L, Qin X, Gao Y Mil Med Res. 2018; 5(1):2.

PMID: 29502526 PMC: 5781318. DOI: 10.1186/s40779-018-0150-0.


Sleep Medication and Athletic Performance-The Evidence for Practitioners and Future Research Directions.

Taylor L, Chrismas B, Dascombe B, Chamari K, Fowler P Front Physiol. 2016; 7:83.

PMID: 27014084 PMC: 4779957. DOI: 10.3389/fphys.2016.00083.


Investigation of the usefulness of zaleplon at two doses to induce afternoon-sleep under noise interference and its effects on psychomotor performance and vestibular function.

Chen L, Zhao A, Zhang Q, Wu F, Ge Z, Ge H Mil Med Res. 2016; 3:5.

PMID: 26937286 PMC: 4774104. DOI: 10.1186/s40779-016-0075-4.